CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.

A synopsis of the Guideline was published in the Canadian Medical Association Journal

A podcast was also produced by CMAJ, which can be found at the link above.

You can also access the Guideline Development Methodology (as supplied by the authors) here

Supplemental Materials

Verified by ExactMetrics